Executive Management Team

William Tew, PhD
CEO

Over 40 Years of entrepreneurial experience. Founder of Chesapeake Biological Laboratories (Baltimore, MD), Glycosan BioSystems (now part of BioTime, Alameda, CA). Also serving as Associate Provost/Assistant Dean of Technology Licensing at the Johns Hopkins University.

Thomas Kennedy, MD, MPH
CMO

Physician and Inventor. Expert in glycosaminoglycan biology. Dr. Kennedy is a co-founder of GlycoMira Therapeutics and ParinGenix (now Cantex Pharma, FL). Previously, he was a Professor of Medicine at the University of Utah and Tulane Medical Center. He received his MD from Vanderbilt University and trainings from the Johns Hopkins Hospital.

Glenn Prestwich, PhD
CSO

Presidential Professor, and Director of Center for Therapeutic Biomaterials at the University of Utah. Dr. Prestwich is a co-founder of GlycoMira, Echelon Biosciences, Glycosan BioSystems, Sentrix Animal Care. He also serves as Chief Science Officer at Symic Bio (San Francisco, CA)

Claus Hakenesch, MBA
CFO

Mr. Hakenesch recently joined GlycoMira with his 20 years of experience in corporate finance, capital raising and public accounting in biotechnology sector. Previously, Mr. Hakenesch worked as Principal at CH Financial Consulting, CFO at ProSciento, Director of Finance at Cyntellect, Manager of Finance at Sequenom (CA). He is also CFO North East Europe at Trescal Group in Germany.

Justin Savage, PhD
VPO

Dr. Savage operates GlycoMira. Previously, he worked at Prolexys (UT). A BYU alum (PhD in Biochemistry)

Gianni Amato, JD, MBA, MPH

Mr. Amato recently joined GlycoMira's management team. Previously he was the Head of Commercial Program Management at Heron Therapeutics, Director of Global Strategic Marketing at Bayer (Germany) and also worked for Pfizer (NY) as Oncology Marketing Analytics consultant. He received his JD from University of Pittsburgh, MBA from Rider University (NJ) and MPH from Tulane University.

Tim Arendt

Mr. Arendt also recently joined GlycoMira's management team. Previously, he was the VP at Neurogesx Corp, Xanodyne Pharma, Valeant Pharma, and GSK. He is also the Managing Director at Syneos Health Consulting (NC). A University of Arizona alum.